01 Oct 2022
PBS Website Update - 1 October 2022
The list of price increases under s104B of the National Health Act 1953 have been updated on the Medicines Supply Security Guarantee web page. An updated list of designated brands as at 1 October 2022 has been published on the Designated Brands web page.
01 Oct 2022
PBS Website Update - 1 October 2022
The list of price increases under s104B of the National Health Act 1953 have been updated on the Medicines Supply Security Guarantee web page. An updated list of designated brands as at 1 October 2022 has been published on the Designated Brands web page.
01 Oct 2022
PBS Website Update - 1 October 2022
The list of price increases under s104B of the National Health Act 1953 have been updated on the Medicines Supply Security Guarantee web page. An updated list of designated brands as at 1 October 2022 has been published on the Designated Brands web page.
19 Sep 2022
PBS- 19th September 2022
Confirmed prices reports for brands to be reduced on 1 October 2022 have now been published on the Current Price Disclosure cycle web page. Brand price reduction reports have also been updated following the conclusion of the dispute resolution administrative process.
19 Sep 2022
PBS- 19th September 2022
Confirmed prices reports for brands to be reduced on 1 October 2022 have now been published on the Current Price Disclosure cycle web page. Brand price reduction reports have also been updated following the conclusion of the dispute resolution administrative process.
19 Sep 2022
PBS- 19th September 2022
Confirmed prices reports for brands to be reduced on 1 October 2022 have now been published on the Current Price Disclosure cycle web page. Brand price reduction reports have also been updated following the conclusion of the dispute resolution administrative process.
09 Sep 2022
PBS-9th September 2022
The Public Summary Documents (first time rejections and deferrals) from the May 2022 Pharmaceutical Benefits Advisory Committee (PBAC) meeting are now available.
09 Sep 2022
PBS-9th September 2022
The Public Summary Documents (first time rejections and deferrals) from the May 2022 Pharmaceutical Benefits Advisory Committee (PBAC) meeting are now available.
09 Sep 2022
PBS-9th September 2022
The Public Summary Documents (first time rejections and deferrals) from the May 2022 Pharmaceutical Benefits Advisory Committee (PBAC) meeting are now available.
05 Sep 2022
PBS News update- 5 September 2022
The Efficient Funding of Chemotherapy (EFC) Review seeks to investigate current processes involved in the production, distribution and access of chemotherapy and other medicines used for the treatment of cancer, that are provided through the Pharmaceutical Benefits Scheme (PBS)
